A new study finds that for 90 percent of patients with severe asthma the therapy with high-dose inhaled steroids - which can have significant side effects - can be replaced by a treatment with a monoclonal antibody called benralizumab, which has much reduced side effects.
related: #asthma #treatment
Contact: info(@)neat-news(dot)com.
neat-news.com is not responsible for the content of external sites.
We do not link to external sites in return for money or any other benefits.
Note that photos are usually stock photos, mostly taken from
Wikipedia, which we can use royalty-free either since they are in
the public domain or available under an open licence such as
a share alike licence.
The page is maintained in Germany and for any legal matters the
laws of Germany apply.
Any warranty or liability is excluded in the widest legally
possible sense.
© neat-news.com 2016-2025.
